The variant E233G of the rad51d gene could be a low-penetrance allele in high-risk breast cancer families without BRCA1/2 mutations

International Journal of Cancer

Volumn 110, Issue 6, 2004, Pages 845-849

  Rodríguez López, Raquel ^a   Osorio, Ana ^a   Ribas, Gloria ^a   Pollán, Marina ^b   Sánchez Pulido, Luis ^c   De La Hoya, Miguel ^d   Ruibal, Álvaro ^e   Zamora, Pilar ^f   Arias, Jose Ignacio ^g   Salazar, Raquel ^h   Vega, Ana ^e   Martínez, Jose Ignacio ⁱ   Esteban Cardeñosa, Eva ^j   Alonso, Carmen ^k   Letón, Rocío ^a   Azcorra, Miguel Urioste ^a   Miner, Cristina ^j   Armengod, M Eugenia ^g   Carracedo, Angel ^e   González Sarmiento, Rogelio ^h   Caldés, Trinidad ^d   Díez, Orland ^k   Benítez, Javier ^a   more..

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e Instituto de Salud Carlos III   (Spain)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g Monte Naranco Hospital   (Spain)

^h Centro de Investigacion del Cancer   (Spain)

ⁱ Cytological Research Institute   (Spain)

^j UNIVERSITY OF VALLADOLID   (Spain)

^k HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

more..

Author keywords

BRCA1 2; Breast cancer; RAD51D

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; RAD51 PROTEIN;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DNA REPAIR; FAMILIAL CANCER; FEMALE; GENE; GENE MUTATION; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PENETRANCE; PREVALENCE; PRIORITY JOURNAL; PROTEIN STABILITY; RAD51C GENE; RAD51D GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

AGE OF ONSET; AMINO ACID SUBSTITUTION; BREAST NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENES, BRCA1; GENES, BRCA2; HUMANS; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES;

EID: 2942625429     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20169     Document Type: Article

References (21)

1. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62:676-89.
2. Scully R, Livingston DM. In search of the tumor-suppressor functions of BRCA1 and BRCA2. Nature 2000;408:429-32.
3. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002;31:33-6.
4. Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, van Duijn C, et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002;31:55-9.
5. Vahteristo P, Bartkova J, Eerola H, Syrjakoski K, Ojala S, Kilpivaara O, Tamminen A, Kononen J, Aittomaki K, Heikkila P, Holli K, Blomqvist C, et al. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 2002;71:432-8.
6. Osorio A, Rodríguez-López R, Diez O, de la Hoya M, Martinez JI, Vega A, Esteban-Cardeñosa E, Alonso C, Carracedo A, Caldes T, Benítez J. The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population. Int J Cancer 2004;108:54-6.
7. Lee JS, Collins KM, Brown AL, Lee CH, Chung JH. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 2000;404:201-4.
8. Davies AA, Masson JY, McIlwraith MJ, Stasiak AZ, Stasiak A, Venkitaraman AR, West SC. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol Cell 2001;7:273-82.
9. Schild D, Lio YC, Collins DW, Tsomondo T, Chen DJ. Evidence for simultaneous protein interactions between human Rad51 paralogs. J Biol Chem 2000;275:16443-9.
10. Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, Lipscombe JM, Day NE, Easton DF, Ponder BA, Pharoah PD, Dunning A. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 2002;11:1399-407.
11. Wang WW, Spurdle AB, Kolachana P, Bove B, Modan B, Ebbers SM, Suthers G, Tucker MA, Kaufman DJ, Doody MM, Tarone RE, Daly M, et al. A single nucleotide polymorphism in the 5′ untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2001;10:955-60.
12. Mohrenweiser HW, Xi T, Vazquez-Matias J, Jones IM. Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol Biomarkers Prev 2002;11:1054-64.
13. Houlston RS, Peto J. The future of association studies of common cancers. Hum Genet 2003;112:434-5.
14. Díaz O, Osorio A, Durán M, Martínez-Ferrandis JI, de la Hoya M, Salazar R, Vega A, Campos B, Rodríguez-López R, Vlasco E, Chaves J, Díaz-Rubio E, et al. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat 2003;22:301-12.
15. Notredame C, Higgins DG, Heringa J. T-Coffee: a novel method for fast and accurate multiple sequence alignment. J Mol Biol 2000;302:205-17.
16. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
17. Palacios J, Honrado E, Osorio A, Cazorla A, Sarrio D, Barroso A, Rodriguez S, Cigudosa JC, Diez O, Lerma E, Rivas C, Benitez J. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 and BRCA2 mutations: differences with breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. Clin Cancer Res 2003;9:3606-14.
18. Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Kochli OR, Mross F, Dieterich H, Moch H, Mihatsch M, Kallioniemi OP, Sauter G. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001;159:2249-56.
19. Kumar S, Bansal M. Dissecting alpha-helices: position-specific analysis of alpha-helices in globular proteins. Proteins 1998;31:460-76.
20. Dong F, Zhou HX. Electrostatic contributions to T4 lysozyme stability: solvent-exposed charges versus semi-buried salt bridges. Biophys J 2002;83:1341-7.
21. Antoniou AC, Easton DF. Polygenic inheritance of breast cancer: implications for design of association studies. Genet Epidemiol 2003;25:190-202.